Never miss a story

Get subscribed to our newsletter


×

Their review is published in the open-access journal ecancermedicalscience.

For patients with a wide range of cancers, taking aspirin as part of their treatment could help to reduce their risk of death by 20 percent, a major review of existing research has suggested. Academics at Cardiff University carried out a systematic review of 118 published observational studies in patients with 18 different cancers.

They pooled the results and found that in a total of nearly 2,50,000 patients with cancer, who reported taking aspirin, this was associated with a reduction of nearly 20 percent in cancer deaths. The review said the available body of evidence on its efficacy and safety "justifies its use" as a supplementary treatment in a wide range of cancers" and patients should be informed of this. Their review is published in the open-access journal ecancermedicalscience.

Aspirin However, we must also stress that aspirin is not a possible alternative to any other treatment Photo by Diana Polekhina on Unsplash


"In recent years, my research team and I have been struck by the actions of aspirin on the biological mechanisms relevant to cancer -- and these seem to be the same in many different cancers," said lead author Peter Elwood, Professor at the varsity. "Overall, we found that at any time after a diagnosis of cancer, nearly 20 percent more of the patients who took aspirin were alive, compared with patients not taking aspirin," he added.

ALSO READ: aspirin risks and benefits

The team also considered the risks of aspirin -- a small number of patients had experienced a bleed, but there was no evidence of any excess deaths attributable to bleeding in the patients on aspirin, the review said. "Our research suggests that not only does aspirin help to cut the risk of death but it has also been shown to reduce the spread of cancer within the body -- so-called metastatic spread," Elwood added.

The team said there is now a considerable body of evidence to suggest a significant reduction in mortality in patients with cancer who take aspirin -- and that benefit appears to not be restricted to one or a few cancers. "Aspirin, therefore, appears to deserve serious consideration as an adjuvant treatment of cancer, and patients with cancer and their carriers should be informed of the available evidence," Elwood added. "However, we must also stress that aspirin is not a possible alternative to any other treatment," he noted. (IANS/JC)


Popular

Unsplash

The researchers exposed saliva samples from Covid-19 patients to the ACE2 gum and found that levels of viral RNA fell so dramatically to be almost undetectable.

A chewing gum laced with a plant-grown protein serves as a "trap" for the SARS-CoV-2 virus, reducing viral load in saliva and potentially tamping down transmission, finds a new study.

The researchers exposed saliva samples from Covid-19 patients to the ACE2 gum and found that levels of viral RNA fell so dramatically to be almost undetectable, indicates the study published in the journal Molecular Therapy.

Follow NewsGram on Instagram to keep yourself updated.

"SARS-CoV-2 replicates in the salivary glands, and we know that when someone d sneezes, coughs, or speaks some of that virus can be expelled and reach others," said researcher Henry Daniell from the University of Pennsylvania in the US.

"This gum offers an opportunity to neutralise the virus in the saliva, giving us a simple way to possibly cut down on a source of disease transmission," Daniell added.

To test the chewing gum, the team grew angiotensin-converting enzyme 2 (ACE2) in plants, paired with another compound that enables the protein to cross mucosal barriers and facilitates binding, and incorporated the resulting plant material into cinnamon-flavoured gum tablets.

Keep Reading Show less

HUH Token

After the release of HUH Token’s White Paper and the buzz around the soon-to-be launching cryptocurrency, it’s no wonder that the crypto world is wondering whether or not Shiba Inu’s year of meme coin supremacy is coming to an end.

Shiba Inu rose to crypto fame in the august of 2020 and just a little over a year from that point, where Shiba Inu knocked Dogecoin off top dog spot… it appears that HUH Token could be set to take the cryptocurrency world by storm on its launch: Monday December 6th. And with it the possible end of Shiba Inu’s reign as the supreme meme coin.

Keep Reading Show less

HUH Token

Investing in the cryptocurrency business is one of the most intelligent choices one can make in the modern-day. In 2021, the sector exhibited its promise, with cryptocurrencies like Ethereum (ETH), Bitcoin (BTC) and Shiba Inu (SHIB) seeing optimistic growth and creating numerous billionaire investors. The market is still in its infancy, and there is an impossible number of exciting cryptocurrencies available for investment. HUH Token, for instance, is one of these, and it is releasing today!

Comprehending a cryptocurrency’s most recent release helps to compare it to previous accomplishments. HUH Token (HUH), Cardano (ADA) and Solana (SOL) are three cryptocurrencies that every crypto trader should be familiar with. These are coins with high usefulness and a robust growth plan. Cardano and Solana are two growing blockchain technologies in the crypto world.

Keep reading... Show less